Prodesse

Waukesha, United States Founded: 1985 • Age: 41 yrs Acquired By Gen-Probe
Molecular diagnostic reagents for infectious diseases are developed.
Request Access

About Prodesse

Prodesse is a company based in Waukesha (United States) founded in 1985 was acquired by Gen-Probe in October 2009.. Prodesse has raised $2.75 million across 3 funding rounds from investors including Gen-Probe. Prodesse operates in a competitive market with competitors including Inflammatix, BioLife Solutions, Visby Medical, Sino Biological and MeMed, among others.

  • Headquarter Waukesha, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.75 M (USD)

    in 3 rounds

  • Latest Funding Round
    $751.43 K (USD), Debt – Convertible

    Jul 19, 2005

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Gen-Probe

    (Oct 06, 2009)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Prodesse

Prodesse has successfully raised a total of $2.75M across 3 strategic funding rounds. The most recent funding activity was a Debt – Convertible round of $751.43 thousand completed in July 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Debt – Convertible — $751,431
  • First Round

    (13 Jun 2002)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2005 Amount Debt – Convertible - Prodesse Valuation

investors

Nov, 2004 Amount Unspecified - Prodesse Valuation

investors

Jun, 2002 Amount Unspecified - Prodesse Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Prodesse

Prodesse has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gen-Probe. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Provides clinical diagnostics, blood screening, and research products.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Prodesse

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Prodesse

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Prodesse Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Prodesse

Prodesse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, BioLife Solutions, Visby Medical, Sino Biological and MeMed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of diagnostic solutions for systemic infections
domain founded_year HQ Location
Tissue hypothermic storage and cryopreservation freeze media are developed.
domain founded_year HQ Location
Portable PCR diagnostics for infectious diseases are developed.
domain founded_year HQ Location
Reagents and kits are provided for clinical research applications.
domain founded_year HQ Location
Provider of machine learning based diagnostic solutions for infectious diseases
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Prodesse

Frequently Asked Questions about Prodesse

When was Prodesse founded?

Prodesse was founded in 1985 and raised its 1st funding round 17 years after it was founded.

Where is Prodesse located?

Prodesse is headquartered in Waukesha, United States. It is registered at Waukesha, Wisconsin, United States.

Is Prodesse a funded company?

Prodesse is a funded company, having raised a total of $2.75M across 3 funding rounds to date. The company's 1st funding round was a Unspecified of $1.55M, raised on Jun 13, 2002.

What does Prodesse do?

Prodesse was founded in 1985 and is headquartered in Waukesha, United States. Reagents for molecular diagnostics in infectious disease detection are created, including tests for human metapneumovirus, mycoplasma pneumoniae, chlamydophila pneumoniae, bordetella pertussis, toxigenic clostridium difficile, and parainfluenza virus. Contract research services and laboratory support are provided, with research-use kits and diagnostic kits available for sale.

Who are the top competitors of Prodesse?

Prodesse's top competitors include Visby Medical, Inflammatix and MeMed.

Who are Prodesse's investors?

Prodesse has 1 investor. Key investors include Gen-Probe.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available